Table 5.
Modules | P value | GO terms |
---|---|---|
1 | 1.97E − 14 | Regulation of protein metabolic process |
2 | 1.32E − 32 | DNA metabolic process |
3 | 2.01E − 28 | Regulation of cAMP metabolic process |
4 | 4.16E − 24 | G-protein coupled receptor signaling pathway |
5 | 5.28E − 23 | DNA-dependent transcription, initiation |
6 | 3.03E − 25 | Transmembrane receptor protein tyrosine kinase signaling pathway |
7 | 4.74E − 23 | Cellular lipid metabolic process |
8 | 6.43E − 15 | Apoptotic process |
9 | 1.80E − 18 | Tricarboxylic acid cycle |
10 | 9.96E − 27 | G-protein coupled receptor signaling pathway |
11 | 1.32E − 32 | Xenobiotic metabolic process |
12 | 2.74E − 15 | Toll-like receptor signaling pathway |
13 | 5.96E − 32 | Potassium ion transport |
14 | 1.50E − 20 | Lipid metabolic process |
15 | 2.57E − 20 | Xenobiotic metabolic process |
16 | 8.66E − 12 | Positive regulation of RNA metabolic process |
17 | 2.78E − 27 | Regulation of blood coagulation |
18 | 3.33E − 14 | Inflammatory response |
19 | 1.94E − 16 | Immune response-activating signal transduction |
20 | 3.65E − 19 | Apoptotic process |
21 | 1.04E − 11 | Regulation of blood coagulation |
22 | 2.64E − 16 | Nucleotide metabolic process |
23 | 4.14E − 13 | Transmembrane receptor protein tyrosine kinase signaling pathway |
24 | 3.85E − 12 | Interferon-gamma-mediated signaling pathway |
25 | 5.59E − 07 | Regulation of cellular protein metabolic process |
26 | 4.34E − 06 | RNA processing |
27 | 1.19E − 22 | Cell cycle phase transition |
28 | 2.71E − 06 | Regulation of RNA metabolic process |
29 | 9.03E − 14 | Regulation of systemic arterial blood pressure by renin-angiotensin |
30 | 5.05E − 18 | Cardiac muscle contraction |
31 | 2.53E − 06 | Regulation of RNA splicing |
32 | 1.13E − 09 | Carbohydrate metabolic process |
33 | 9.21E − 14 | Insulin receptor signaling pathway |
34 | 3.77E − 08 | Lipid catabolic process |
35 | 2.50E − 22 | Cellular amino acid catabolic process |
36 | 1.93E − 17 | Regulation of cell cycle |
37 | 2.42E − 14 | Lipid metabolic process |
38 | 3.52E − 17 | mRNA metabolic process |
39 | 2.31E − 06 | Execution phase of apoptosis |
40 | 1.16E − 15 | Toll-like receptor signaling pathway |
41 | 3.70E − 11 | RNA biosynthetic process |
42 | 3.65E − 12 | Cell cycle phase |
43 | 2.80E − 12 | Cellular amino acid metabolic process |
44 | 6.84E − 05 | Regulation of cell proliferation |
45 | 1.17E − 07 | Inflammatory response |
46 | 4.51E − 09 | RNA biosynthetic process |
47 | 3.74E − 11 | Regulation of interleukin-1 secretion |
48 | 1.49E − 13 | DNA repair |
49 | 1.67E − 18 | Insulin receptor signaling pathway |
50 | 3.18E − 06 | Negative regulation of RNA metabolic process |
51 | 1.24E − 04 | Transport |
52 | 8.34E − 14 | Regulation of transforming growth factor beta receptor signaling pathway |
53 | 4.47E − 06 | Xenobiotic metabolic process |
54 | 1.16E − 08 | Negative regulation of inflammatory response |
55 | 1.37E − 07 | Positive regulation of RNA metabolic process |
56 | 5.56E − 07 | Transmission of nerve impulse |
57 | 5.79E − 12 | Mitotic cell cycle |
58 | 6.69E − 06 | Negative regulation of protein metabolic process |
59 | 2.66E − 12 | Regulation of apoptotic signaling pathway |
60 | 2.00E − 09 | Regulation of apoptotic signaling pathway |
61 | 2.47E − 11 | NIK/NF-kappaB cascade |
62 | 4.69E − 15 | Vascular endothelial growth factor receptor signaling pathway |
63 | 1.98E − 06 | DNA metabolic process |
64 | 2.04E − 04 | Chromatin organization |
65 | 1.11E − 05 | DNA packaging |
66 | 9.39E − 07 | Inflammatory response |
67 | 3.22E − 09 | Xenobiotic metabolic process |
68 | 8.09E − 12 | Insulin receptor signaling pathway |
69 | 8.52E − 04 | DNA-dependent transcription, initiation |
70 | 1.56E − 05 | DNA replication |
71 | 5.51E − 07 | Toll-like receptor signaling pathway |
72 | 2.16E − 08 | Copper ion import |
73 | 2.90E − 08 | Transmission of nerve impulse |
74 | 4.63E − 07 | Regulation of blood coagulation |
76 | 6.90E − 04 | Alanine catabolic process |
77 | 6.76E − 05 | RNA biosynthetic process |
78 | 7.60E − 04 | Lipid metabolic process |
79 | 2.86E − 05 | TRIF-dependent toll-like receptor signaling pathway |
81 | 4.18E − 05 | Regulation of type I interferon production |
83 | 5.21E − 03 | Cellular lipid metabolic process |
84 | 1.27E − 11 | Neural crest cell migration |
85 | 2.10E − 03 | AMP catabolic process |
Notes. P value is the probability of obtaining the observed effect under the null hypothesis; a very small P value indicates that the observed effect is very unlikely to have arisen purely by chance.